Incyte | INCY - Zobowiązania





Zobowiązania Zmiana Data
Acadia Pharmaceuticals USD 332.22M 29.22M 2026-09
Agenus USD 231.82M 17.42M 2026-06
Agios Pharmaceuticals USD 77.59M 7.37M 2026-09
Alnylam Pharmaceuticals USD 2.06B 550.49M 2026-09
Amgen USD 23.23B 2.27B 2026-09
BioCryst Pharmaceuticals USD 195.83M 13.02M 2026-09
Biogen USD 3.9B 18.7M 2026-09
BioMarin Pharmaceutical USD 1.6B 59.17M 2026-09
Bristol-Myers Squibb USD 18.75B 94M 2026-09
Eli Lilly USD 47B 745M 2026-09
Exelixis USD 411.88M 49.95M 2026-09
Gilead Sciences USD 12B 982M 2026-09
Incyte USD 1.44B 125.72M 2026-09
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
MacroGenics USD 108.82M 12.88M 2026-06
Merck USD 28.8B 1.07B 2026-09
Moderna USD 2.03B 506M 2026-09
Nektar Therapeutics USD 57.71M 4.17M 2026-03
Neurocrine Biosciences USD 984.6M 110.1M 2026-09
Novartis USD 32.52B 777M 2026-09
Novartis USD 32.52B 1.15B 2026-09
Pfizer USD 31.73B 920M 2026-09
PTC Therapeutics USD 776.08M 5.01M 2026-09
Puma Biotechnology USD 82.73M 3.63M 2025-09
Regeneron Pharmaceuticals USD 6.2B 671.5M 2026-09
Sarepta Therapeutics USD 656.35M 153.44M 2026-09
Ultragenyx Pharmaceutical USD 389M 38M 2026-09
Vertex Pharmaceuticals USD 5B 1.06B 2026-09